P2RX1 promotes mitochondrial apoptosis via calcium/CaM KII-mediated suppression of PI3K/Akt signaling in Philadelphia chromosome-positive acute lymphoblastic leukemia. [PDF]
Li XB, Ren Q, Ye XM, Li JL, Feng LG.
europepmc +1 more source
Asciminib plus dasatinib and prednisone for Philadelphia chromosome-positive acute leukemia.
Luskin MR +16 more
europepmc +1 more source
Rapid development of Philadelphia chromosome-negative AML in a CML patient with sustained major molecular response to tyrosine kinase inhibitor therapy. [PDF]
Liu H +6 more
europepmc +1 more source
[Safety of blinatumomab combined with dasatinib in the treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia]. [PDF]
Zheng FY +5 more
europepmc +1 more source
Impact of clinical response and treatment tolerability on HRQoL in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia patients treated with ponatinib or imatinib. [PDF]
Ashaye A +13 more
europepmc +1 more source
Characterization and Clinical Outcome of Philadelphia Chromosome-Positive AML in Thrombocytopenia-Absent Radius Syndrome. [PDF]
Villar-Prados A +4 more
europepmc +1 more source
Differential expression and functional analysis of circular RNAs and m6A modifications in children with Philadelphia chromosome-positive acute lymphoblastic leukemia. [PDF]
Xie L +7 more
europepmc +1 more source
Results of the Simultaneous Combination of Ponatinib and Blinatumomab in Philadelphia Chromosome-Positive ALL. [PDF]
Kantarjian H +17 more
europepmc +1 more source

